We are offering optional CME activities:
- Why Refractive Lens Exchange is Growing So Rapidly
- Role Play and Reflection – The Implant Consultation
- Campfire Chat with All Faculty
- Role Play and Reflection – The Frustrated Patient
- Refractive Enhancement Options
- Campfire Chat with All Faculty
The inaugural ASCRS Business of Refractive Cataract Surgery (BRiCS) Summit also features a CME curriculum designed to provide a comprehensive and interactive learning experience tailored to both experienced surgeons and those looking to enhance their skills. This curriculum combines didactic presentations, role playing sessions, and faculty-led roundtable discussions. The expert faculty will deliver evidence-based lectures on refractive lens exchange and refractive enhancement options within refractive cataract surgery. Following the lectures, participants engage in role playing exercises that simulate real-world scenarios and allow attendees to refine their communication skills. The roundtable discussions facilitate deeper exploration of case studies, enabling participants to collaboratively analyze complex clinical situations, discuss individual experiences, and problem-solve with guidance from expert surgeons. This multifaceted approach ensures that participants gain both the technical knowledge and the practical skills needed to deliver optimal outcomes in refractive cataract surgery.
CME Mission Statement
ASCRS’ continuing medical education mission is to improve the competence of ophthalmologists/anterior segment surgeons by offering an avenue for the presentation and discussion of innovative techniques and technologies and fostering an open environment where current practices are presented and questions and improvements in patient care are continually sought.
Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.
Designation Statement
The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Attendees registered as exhibitors are not eligible for CME credits.
Target Audience
Anterior segment specialists, comprehensive ophthalmologists, residents, fellows, practice implementors.
Educational Objectives
Upon completion of this program, participants should be able to:
- Compare refractive IOLs and provide practical pearls and pitfalls for implanting different refractive IOLs.
- Examine refractive lens exchange and discuss selecting patients and determining the best individual refractive IOL choice.
- Outline how to establish or enhance a refractive IOL practice and how to improve communication efficacy.
- Employ tips for office and organization workflow that are specific to the evaluation and counseling of a refractive IOL patient.
- Discuss management of an unhappy refractive IOL patient and refractive or surgical complications.
- Recognize when to consider a refractive enhancement.
- Compare and contrast refractive enhancement options: Lasik, PRK, Piggyback lenses, LRI’s at the slit lamp, utilizing a femtosecond laser and YAG timing.
- Employ strategies for lens exchange techniques and/or how to enhance a lens.
Notice About Off-Label Use Presentations
The educational program may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.
Claim CME/CE Credits
Attendees will receive a post event survey and CME credit claim on Monday, September 30, 2024 via email. Please contact cme@ascrs.org with any questions on credit claims.
Relevant Financial Interest Index
As a provider accredited by the Accreditation council for Continuing Medical Education, ASCRS must ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly provided activities.
All individuals participating in an activity designated for CME credit must disclose any financial interest or relationship with an ineligible company that produces, markets, sells, resells, or distributes ophthalmic products/devices/drugs or services used on or by patients that are discussed in an educational presentation or lack thereof. Financial interest can include such things as grants or research support, consultant, stockholder, member of speaker’s bureau, et.
The intent of this disclosure is not to disqualify anyone from participating, but to provide the program committee with information so they can design and implement a balanced, independent, and scientific educational activity. The Financial Interest Index provides information to attendees, so they can make their own judgement regarding the interest or relationship and the materials presented. A complete listing of relations disclosed, and their corresponding codes are below.
Patti Barkey, COE has no relevant financial interests.
Deborah Davis, COE has no relevant financial interests.
Nicole Fram, MD is an advisor for Johnson & Johnson. She is a consultant for Alcon, BVI, Carl Zeiss Meditec, Johnson & Johnson, and RxSight. She is a researcher for Carl Zeiss Meditec. She is a speaker for Alcon, Carl Zeiss Meditec, Johnson & Johnson, and RxSight.
Carrie Jacobs, COE is a consultant for Alcon.
Matt Jensen is a consultant for RxSight.
Jaime Johannesen has no relevant financial interests.
Richard Lindstrom, MD is a consultant for Alcon, Bausch & Lomb, and Lenstec. He has received royalties or is a patent beneficiary from Bausch & Lomb.
Vance Thompson, MD is a consultant for Alcon, Bausch & Lomb, BVI, Carl Zeiss Meditec, Johnson & Johnson, LENSAR, Rayner, RxSight, and STAAR. He is a researcher for Alcon, Bausch & Lomb, BVI, Carl Zeiss Meditec, Johnson & Johnson, Rayner, RxSight, and STAAR. He receives stock options from Rayner. He holds individual stocks from a publicly traded organization with Bausch & Lomb, Johnson & Johnson, LENSAR, and RxSight.
Richard Tipperman, MD is an advisor for Alcon and BVI.
Robert Weinstock, MD is an advisor for Bausch & Lomb, BVI, and Johnson & Johnson. He is a consultant for Alcon, Bausch & Lomb, BVI, and Johnson & Johnson. He holds individual stocks from a publicly traded organization with RxSight. He is a speaker for Bausch & Lomb.
William Wiley, MD is an advisor for Alcon, Atia Vision, Bausch & Lomb, BVI, Carl Zeiss Meditec, Johnson & Johnson, Rayner, and STAAR. He is a consultant for Alcon, Atia Vision, Bausch & Lomb, Carl Zeiss Meditec, Rayner, and STAAR. He is a researcher for Alcon, Bausch & Lomb, BVI, Carl Zeiss Meditec, Johnson & Johnson, Rayner, and STAAR. He is a speaker for Alcon, BVI, and Johnson & Johnson. He holds individual stocks from a publicly held organization with RxSight.
Blake Williamson, MD is a consultant for Bausch & Lomb, BVI, Johnson & Johnson, and STAAR.
Dagny Zhu, MD is an advisor for Alcon, Bausch & Lomb, and Johnson & Johnson. She is a consultant for Alcon, Bausch & Lomb, Johnson & Johnson, and STAAR. She is a speaker for Alcon and Johnson & Johnson.
Crista Parker, Carrie Braden, Nicole Hanson-Emerson, Lindsay Kunz, and Angela Nichols, ASCRS Staff, have no financial interests.
All relevant financial relationships for these individuals have been mitigated.